Literature DB >> 22696596

Exome sequencing identifies MXRA5 as a novel cancer gene frequently mutated in non-small cell lung carcinoma from Chinese patients.

Donghai Xiong1, Guangming Li, Kezhen Li, Qinzi Xu, Zhongjie Pan, Feng Ding, Peter Vedell, Pengyuan Liu, Peng Cui, Xing Hua, Hui Jiang, Yuxin Yin, Ze Zhu, Xiaomian Li, Bin Zhang, Ding Ma, Yian Wang, Ming You.   

Abstract

Lung cancer has become the top killer among malignant tumors in China and is significantly associated with somatic genetic alterations. We performed exome sequencing of 14 non-small cell lung carcinomas (NSCLCs) with matched adjacent normal lung tissues extracted from Chinese patients. In addition to the lung cancer-related genes (TP53, EGFR, KRAS, PIK3CA, and ROS1), this study revealed "novel" genes not previously implicated in NSCLC. Especially, matrix-remodeling associated 5 was the second most frequently mutated gene in NSCLC (first is TP53). Subsequent Sanger sequencing of matrix-remodeling associated 5 in an additional sample set consisting of 52 paired tumor-normal DNA samples revealed that 15% of Chinese NSCLCs contained somatic mutations in matrix-remodeling associated 5. These findings, together with the results from pathway analysis, strongly indicate that altered extracellular matrix-remodeling may be involved in the etiology of NSCLC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22696596      PMCID: PMC3514907          DOI: 10.1093/carcin/bgs210

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  37 in total

1.  VarScan: variant detection in massively parallel sequencing of individual and pooled samples.

Authors:  Daniel C Koboldt; Ken Chen; Todd Wylie; David E Larson; Michael D McLellan; Elaine R Mardis; George M Weinstock; Richard K Wilson; Li Ding
Journal:  Bioinformatics       Date:  2009-06-19       Impact factor: 6.937

Review 2.  Role of leucine-rich repeat proteins in the development and function of neural circuits.

Authors:  Joris de Wit; Weizhe Hong; Liqun Luo; Anirvan Ghosh
Journal:  Annu Rev Cell Dev Biol       Date:  2011-07-05       Impact factor: 13.827

3.  Aberrant DNA methylation of some tumor suppressor genes in lung cancers from workers with chromate exposure.

Authors:  Abdellah H K Ali; Kazuya Kondo; Toshiaki Namura; Yoshitaka Senba; Hiromitsu Takizawa; Yasushi Nakagawa; Hiroaki Toba; Koichiro Kenzaki; Shoji Sakiyama; Akira Tangoku
Journal:  Mol Carcinog       Date:  2010-11-23       Impact factor: 4.784

4.  Cancer. Aneuploidy drives a mutator phenotype in cancer.

Authors:  Richard D Kolodner; Don W Cleveland; Christopher D Putnam
Journal:  Science       Date:  2011-08-19       Impact factor: 47.728

5.  Reduction in drug-induced DNA double-strand breaks associated with beta1 integrin-mediated adhesion correlates with drug resistance in U937 cells.

Authors:  L A Hazlehurst; N Valkov; L Wisner; J A Storey; D Boulware; D M Sullivan; W S Dalton
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

6.  Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis.

Authors:  Olaug Kristin Rødningen; Anne-Lise Børresen-Dale; Jan Alsner; Trevor Hastie; Jens Overgaard
Journal:  Radiother Oncol       Date:  2007-10-25       Impact factor: 6.280

7.  Tumor-derived extracellular mutations of PTPRT /PTPrho are defective in cell adhesion.

Authors:  Jianshi Yu; Scott Becka; Peng Zhang; Xiaodong Zhang; Susann M Brady-Kalnay; Zhenghe Wang
Journal:  Mol Cancer Res       Date:  2008-07       Impact factor: 5.852

8.  CancerResource: a comprehensive database of cancer-relevant proteins and compound interactions supported by experimental knowledge.

Authors:  Jessica Ahmed; Thomas Meinel; Mathias Dunkel; Manuela S Murgueitio; Robert Adams; Corinna Blasse; Andreas Eckert; Saskia Preissner; Robert Preissner
Journal:  Nucleic Acids Res       Date:  2010-10-15       Impact factor: 16.971

9.  A small-cell lung cancer genome with complex signatures of tobacco exposure.

Authors:  Erin D Pleasance; Philip J Stephens; Sarah O'Meara; David J McBride; Alison Meynert; David Jones; Meng-Lay Lin; David Beare; King Wai Lau; Chris Greenman; Ignacio Varela; Serena Nik-Zainal; Helen R Davies; Gonzalo R Ordoñez; Laura J Mudie; Calli Latimer; Sarah Edkins; Lucy Stebbings; Lina Chen; Mingming Jia; Catherine Leroy; John Marshall; Andrew Menzies; Adam Butler; Jon W Teague; Jonathon Mangion; Yongming A Sun; Stephen F McLaughlin; Heather E Peckham; Eric F Tsung; Gina L Costa; Clarence C Lee; John D Minna; Adi Gazdar; Ewan Birney; Michael D Rhodes; Kevin J McKernan; Michael R Stratton; P Andrew Futreal; Peter J Campbell
Journal:  Nature       Date:  2009-12-16       Impact factor: 49.962

10.  Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma.

Authors:  Chunyu Zhang; Li Fu; Jianhua Fu; Liang Hu; Hong Yang; Tie-Hua Rong; Yan Li; Haibo Liu; Song-Bin Fu; Yi-Xin Zeng; Xin-Yuan Guan
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

View more
  24 in total

Review 1.  The promise of whole-exome sequencing in medical genetics.

Authors:  Bahareh Rabbani; Mustafa Tekin; Nejat Mahdieh
Journal:  J Hum Genet       Date:  2013-11-07       Impact factor: 3.172

2.  A recurrent mutation in PARK2 is associated with familial lung cancer.

Authors:  Donghai Xiong; Yian Wang; Elena Kupert; Claire Simpson; Susan M Pinney; Colette R Gaba; Diptasri Mandal; Ann G Schwartz; Ping Yang; Mariza de Andrade; Claudio Pikielny; Jinyoung Byun; Yafang Li; Dwight Stambolian; Margaret R Spitz; Yanhong Liu; Christopher I Amos; Joan E Bailey-Wilson; Marshall Anderson; Ming You
Journal:  Am J Hum Genet       Date:  2015-01-29       Impact factor: 11.025

Review 3.  Next-generation sequencing in the clinic: promises and challenges.

Authors:  Jiekun Xuan; Ying Yu; Tao Qing; Lei Guo; Leming Shi
Journal:  Cancer Lett       Date:  2012-11-19       Impact factor: 8.679

4.  Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing.

Authors:  Margaret L Hoang; Chung-Hsin Chen; Viktoriya S Sidorenko; Jian He; Kathleen G Dickman; Byeong Hwa Yun; Masaaki Moriya; Noushin Niknafs; Christopher Douville; Rachel Karchin; Robert J Turesky; Yeong-Shiau Pu; Bert Vogelstein; Nickolas Papadopoulos; Arthur P Grollman; Kenneth W Kinzler; Thomas A Rosenquist
Journal:  Sci Transl Med       Date:  2013-08-07       Impact factor: 17.956

5.  Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy for non-small cell lung cancer.

Authors:  Yu-Tao Liu; Xiao-Hong Han; Pu-Yuan Xing; Xing-Sheng Hu; Xue-Zhi Hao; Yan Wang; Jun-Ling Li; Zhi-Shang Zhang; Zhi-Hao Yang; Yuan-Kai Shi
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

6.  Comprehensive Analysis of the Transcriptome-Wide m6A Methylome in Pterygium by MeRIP Sequencing.

Authors:  Yaping Jiang; Xin Zhang; Xiaoyan Zhang; Kun Zhao; Jing Zhang; Chuanxi Yang; Yihui Chen
Journal:  Front Cell Dev Biol       Date:  2021-06-25

7.  Targeted next-generation sequencing for cancer-associated gene mutation and copy number detection in 206 patients with non-small-cell lung cancer.

Authors:  Songbai Zheng; Xiaodan Wang; Ying Fu; Beibei Li; Jianhua Xu; Haifang Wang; Zhen Huang; Hui Xu; Yurong Qiu; Yaozhou Shi; Kui Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  Mechanisms of base substitution mutagenesis in cancer genomes.

Authors:  Albino Bacolla; David N Cooper; Karen M Vasquez
Journal:  Genes (Basel)       Date:  2014-03-05       Impact factor: 4.096

9.  Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers.

Authors:  Jin Woo Ahn; Han Sang Kim; Jung-Ki Yoon; Hoon Jang; Soo Min Han; Sungho Eun; Hyo Sup Shim; Hyun-Jung Kim; Dae Joon Kim; Jin Gu Lee; Chang Young Lee; Mi Kyung Bae; Kyung Young Chung; Ji Ye Jung; Eun Young Kim; Se Kyu Kim; Joon Chang; Hye Ryun Kim; Joo Hang Kim; Min Goo Lee; Byoung Chul Cho; Ji Hyun Lee; Duhee Bang
Journal:  Genome Med       Date:  2014-02-27       Impact factor: 11.117

10.  MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.

Authors:  Jin-Zhang Sun; Jin-Hao Zhang; Jia-Bo Li; Feng Yuan; Lu-Qing Tong; Xu-Ya Wang; Lu-Lu Chen; Xiao-Guang Fan; Yi-Ming Zhang; Xiao Ren; Chen Zhang; Sheng-Ping Yu; Xue-Jun Yang
Journal:  Dis Markers       Date:  2021-06-09       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.